Selected Grants
Induced Suppression of Platelet Activity in Aneurysmal SAH Management-2 (iSPASM-2)
Clinical TrialInvestigator · Awarded by National Institutes of Health · 2025 - 2030Genetic variation, stress, and functional outcomes after stroke rehabilitation
Clinical TrialPrincipal Investigator · Awarded by University of California - Irvine · 2018 - 2021Randomized Double Blind Placebo-Controlled Parallel Group, MultiCenter Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema following Larg
Clinical TrialPrincipal Investigator · Awarded by Biogen, Inc. · 2018 - 2021MicroRNA Profiling to Characterize and Predict Posttraumatic Epilepsy following Traumatic Brain Injury
ResearchCo Investigator · Awarded by Department of Defense · 2018 - 2020Management of Acute Stroke Patients on Treatment with New Oral Anticoagulants: Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry" (the "Registry")
ResearchPrincipal Investigator · Awarded by Duke Clinical Research Institute · 2017 - 2020External Relationships
- Roberts Carroll Feldstein and Peirce
- Syneos Health
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.